Lipoprotein(a) Reduction in Persons with Cardiovascular Disease. Reply
N Engl J Med
.
2020 May 21;382(21):e65.
doi: 10.1056/NEJMc2004861.
Authors
Sotirios Tsimikas
1
,
Ewa Karwatowska-Prokopczuk
2
,
Shuting Xia
3
Affiliations
1
University of California, San Diego, La Jolla, CA
[email protected]
.
2
Akcea Therapeutics, Boston, MA.
3
Ionis Pharmaceuticals, Carlsbad, CA.
PMID:
32433854
DOI:
10.1056/NEJMc2004861
No abstract available
Publication types
Letter
Comment
MeSH terms
Cardiovascular Diseases*
Cholesterol, LDL
Humans
Lipoprotein(a)*
Risk Factors
Substances
Cholesterol, LDL
Lipoprotein(a)